Loading the map…
Research and experimental development on biotechnology · London
Hemogenyx Pharmaceuticals
Hemogenyx Pharmaceuticals PLC
Public limited company registered in London, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Dec 2024 · Group consolidated
Turnover
For subscribers
Profit after tax
−£5.63m
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
3 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2022 | 2023 | 2024 |
|---|---|---|---|
| Profit after tax | −£5.63m | ||
| Turnover | |||
| Net assets | |||
| Cash | |||
| Employees | |||
| Retained reserves |
Every figure for all 3 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current assets | |||
| of which cash | |||
| Creditors due within a year | |||
| Creditors due after a year | |||
| Net assets | |||
| Ratios | |||
| Return on equityProfit after tax as a share of net assets | |||
| Current ratioCurrent assets for every £1 owed within a year | |||
| Cash ratioCash for every £1 owed within a year | |||
5 balance-sheet lines and 3 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-24
- SharesStatement of capital following an allotment of shares on 8 September 2026 · GBP 14,052,082.3403 (and 34 more like it since 20 November 2016)
- FilingResolutions (and 12 more like it since 4 July 2016)
- AccountsGroup of companies' accounts made up to 31 December 2025
- AccountsGroup of companies' accounts made up to 31 December 2024
- AddressRegistered office address changed from 6th Floor 60 Gracechurch Street London EC3V 0HR United Kingdom to 6 Heddon Street London W1B 4BT on 3 January 2025
- DirectorsAppointment of Westend Corporate Llp as a secretary on 1 January 2025
- DirectorsTermination of appointment of Ben Harber as a secretary on 31 December 2024
- SharesConsolidation of shares on 9 December 2024
- SharesSub-division of shares on 9 December 2024
- FilingMemorandum and Articles of Association (and 1 more like it since 20 July 2021)
- AccountsGroup of companies' accounts made up to 31 December 2023
- AccountsGroup of companies' accounts made up to 31 December 2022
26 earlier
- DirectorsAppointment of Mr Ben Harber as a secretary on 27 June 2023
- DirectorsTermination of appointment of Andrew Wright as a secretary on 27 June 2023
- AddressRegistered office address changed from 5 Fleet Place London EC4M 7rd England to 6th Floor 60 Gracechurch Street London EC3V 0HR on 12 July 2022
- AccountsGroup of companies' accounts made up to 31 December 2021
- AccountsGroup of companies' accounts made up to 31 December 2020
- AccountsGroup of companies' accounts made up to 31 December 2019
- OwnershipCessation of Vladislav Sandler as a person with significant control on 4 October 2018
- OwnershipCessation of Alexis Sandler as a person with significant control on 4 October 2018
- AccountsGroup of companies' accounts made up to 31 December 2018
- DirectorsTermination of appointment of Robin William Campbell as a director on 5 January 2019
- OwnershipNotification of Vladislav Sandler as a person with significant control on 5 October 2017
- OwnershipNotification of Alexis Sandler as a person with significant control on 5 October 2017
- DirectorsAppointment of Mr Andrew Wright as a secretary on 5 November 2018
- DirectorsTermination of appointment of Lawrence Pemble as a director on 5 November 2018
- SharesSecond filing of a statement of capital following an allotment of shares on 5 October 2017 · GBP 3,600,513.60
- DirectorsTermination of appointment of Adrian Richard Thorpe Beeston as a director on 9 April 2018
- DirectorsAppointment of Sir Marc Feldmann as a director on 9 April 2018
- AccountsGroup of companies' accounts made up to 31 December 2017
- DirectorsTermination of appointment of Timothy Vincent Le Druillenec as a secretary on 30 November 2017
- DirectorsTermination of appointment of Timothy Vincent Le Druillenec as a director on 30 November 2017
- DirectorsAppointment of Mr Lawrence Pemble as a director on 4 October 2017
- DirectorsAppointment of Dr Vladislav Sandler as a director on 4 October 2017
- DirectorsAppointment of Mr Timothy Vincent Le Druillenec as a director on 4 October 2017
- DirectorsAppointment of Dr Robin William Campbell as a director on 4 October 2017
- DirectorsAppointment of Ms Alexis Sandler as a director on 4 October 2017
- DirectorsTermination of appointment of Geoffrey Gilbert Dart as a director on 4 October 2017
- Directors
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Hemogenyx Pharmaceuticals do?
Public limited company registered in London, classed under “Research and experimental development on biotechnology”.
›How much turnover does Hemogenyx Pharmaceuticals make?
Answered in the full report
›Is Hemogenyx Pharmaceuticals profitable?
No: it made a loss after tax of £5.63m in the year to 31 December 2024, its latest filed accounts.
›Who runs and owns Hemogenyx Pharmaceuticals?
Its directors are LLP, Westend Corporate, Marc Feldmann, Peter Redmond, Alexis Sandler, Vladislav Sandler. Its owners are shown to subscribers.
›Where is Hemogenyx Pharmaceuticals based?
Its registered office is 6 Heddon Street, London, W1B 4BT, in London.
›When was Hemogenyx Pharmaceuticals founded?
Hemogenyx Pharmaceuticals PLC was incorporated on 13 February 2013.
›Is Hemogenyx Pharmaceuticals still trading?
The register lists Hemogenyx Pharmaceuticals PLC as active.